mirikizumab

Italy

Drugs containing this active substance

  • OMVOH

    It is used for the treatment of inflammatory bowel diseases, specifically ulcerative colitis and Crohn's disease, to reduce signs and symptoms such as diarrhea, abdominal pain, urgency, and rectal bleeding.

    Form: solution for infusion, concentrate

    Active substance Dosage
    mirikizumab -

    ATC: L04AC24

    Manufacturer: ELI LILLY NEDERLAND B.V.